Biotech - Press Releases

Date	Title	Company
02-Dec-2019	Destiny Pharma to present at the Partnerships to Tackle the Global Challenge of AMR, UK-China AMR Workshop	Destiny Pharma plc
02-Dec-2019	Cambridge Innovation Capital has attracted £1 billion of investment into Cambridge companies	Cambridge Innovation Capital
02-Dec-2019	Lewis Cameron, Former Head of Global Clinical Development at Covance, Appointed as Chief Operating Officer	Ergomed plc
02-Dec-2019	ABPI appoints Dr Richard Torbett as new Chief Executive	The Association of the British Pharmaceutical Industry (ABPI)
02-Dec-2019	Elucid Health achieves 100% robustness in ongoing trials of their Pill Connect smart pill bottle that could help improve adherence to medications	Elucid Health
02-Dec-2019	NICE EXPANDS RECOMMENDATION FOR LYNPARZATM (OLAPARIB) TABLETS FOR WOMEN WITH RELAPSED, BRCA-MUTATED, ADVANCED OVARIAN CANCER[I]	AstraZeneca
02-Dec-2019	BioMed X Reaches Milestone in Respiratory Disease Research Collaboration with Boehringer Ingelheim	BioMed X Innovation Center
02-Dec-2019	Akari Therapeutics Announces Pivotal Phase III Trial Design of Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA), Following FDA Meeting	Akari Therapeutics
02-Dec-2019	iPatientAxis Announces Early Participation in Newly Launched AWS Data Exchange	iPatientAxis
02-Dec-2019	Bayer selects Pharmaron as partner organization	Bayer
02-Dec-2019	European CNS specialist Neuraxpharm expands Southern European presence with expansion into Portugal	Neuraxpharm Group (Neuraxpharm)
02-Dec-2019	One Nucleus announces finalists of the BioNewsRound Award	One Nucleus
02-Dec-2019	PENTAX Medical Video Duodenoscope ED34-i10T2 receives FDA clearance	PENTAX Medical
02-Dec-2019	ICR responds to NICE approval of palbociclib for treating advanced breast cancer after hormone therapy	The Institute of Cancer Research
02-Dec-2019	FOR THE USE OF VAL201 IN THE PREVENTION AND TREATMENT OF METASTATIC CANCER	About ValiRx
02-Dec-2019	New recommendations to stimulate braver and bolder communications	The Healthcare Communications Association (HCA)
02-Dec-2019	Reclassification of series B shares in Moberg Pharma AB (publ)	Moberg Pharma AB
02-Dec-2019	Orgenesis Ranked 5th Fastest Growing Technology Company in Maryland and 208th in North America on Deloitte's 2019 Technology Fast 500	Orgenesis
02-Dec-2019	Evofem Biosciences Reports Positive Top-Line Results from Phase 2b Study of Amphora® for Prevention of Chlamydia and Gonorrhea in Women	Evofem Biosciences, Inc.
02-Dec-2019	Oncopeptides Appoints Joseph Horvat as President North America	Oncopeptides AB